Interferon Enhances the Fragility of Lysosomes in L-929 Mouse Fibroblasts

References

1. Allison A. C., Sandelin K. 1963; Activation of lysosomal enzymes in virus-infected cells and its possible relationship to cytopathic effects. Journal of Experimental Medicine 117:879–887
   [Google Scholar]
2. Dahl H., Degre M. 1975; Separation of antiviral activity of human interferon from cell growth inhibitory effect. Nature, London 257:799–801
   [Google Scholar]
3. Deduve C. 1963; The Lysosome Concept. In The Lysosomes. Ciba Foundation Symposium Edited BY De Reuck A. V. S., Cameron M. P. London: J. & A. Chuichill Ltd;
   [Google Scholar]
4. Defendi V. 1962; Cytopathology of virus infection. Federation Proceedings of the American Society of Experimental Biology 21:1113–1117
   [Google Scholar]
5. Gresser I., Brouty-Boye D., Thomas M.-T., Macieira-Coelho A. 1970; Interferon and cell division. I. Inhibition of the multiplication of mouse leukemia L 1210 cells in vitro by interferon preparations. Proceedings of the National Academy of Sciences of the United States of America 66:1052–1058
   [Google Scholar]
6. Gresser I., Thomas M.-T., Brouty-Boye D., Macieira-Coelho A. 1971; Interferon and cell division. V. Titration of the anticellular action of interferon preparations. Proceedings of the Society for Experimental Biology and Medicine 137:1258
   [Google Scholar]
7. Guskey L. E., Smith P. C., Wolff D. A. 1970; Patterns of cytopathology and lysosomal enzyme release in poliovirus infected HEp-2 cells treated with either 2 (α-hydroxybenzyl)-benzimidazole or guanidine-HCl. Journal of General Virology 6:151–161
   [Google Scholar]
8. Horak I., Jungwirth C., Bodo G. 1971; Poxvirus-specific cytopathic effect in interferon-treated L cells. Virology 45:456–462
   [Google Scholar]
9. Isaacs A., Lindenmann J. 1957; Virus interference. I. The interferon. Proceedings of the Royal Society B 147:258–267
   [Google Scholar]
10. Joklik W. K., Merigan T. C. 1966; Concerning the mechanism of action of interferon. Proceedings of the National Academy of Sciences of the United States of America 56:558–565
    [Google Scholar]
11. Jungwirth C., Horak I., Bodo G., Lindner J., Schultze B. 1972; The synthesis of poxvirus-specific RNA in interferon-treated cells. Virology 48:59–70
    [Google Scholar]
12. Knight E. 1976; Antiviral and cell growth inhibition activities reside in the same glycoprotein of human fibroblast interferon. Nature, London 262:302–303
    [Google Scholar]
13. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. 1951; Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 193:265–275
    [Google Scholar]
14. Stewart W. E. II, Gosser L. B., Lockart R. Z. Jun 1971; Priming: a non-antiviral function of interferon. Journal of Virology 7:792–801
    [Google Scholar]
15. Stewart W. E. II, De Clerq E., De Somer P., Berg K., Ogburn C. A., Paucker K. 1973; Antiviral and non-antiviral activity of highly purified interferon. Nature New Biology 246:141–143
    [Google Scholar]
16. Tan Y. H. 1976; Chromosome 21 and the cell growth inhibitory effect of human interferon preparations. Nature, London 260:141–143
    [Google Scholar]
17. Wigzell H. 1965; Quantitative titrations of mouse H-2 antibodies using ⁵¹Cr-labelled target cells. Transplantation 3:423–431
    [Google Scholar]
18. Wolff D. A., Bubel J. C. 1964; The disposition of lysosomal enzymes as related to specific viral cytopathic effects. Virology 24:502–505
    [Google Scholar]